Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study - Jakacki, R I; Cohen, K J; Buxton, A (Neuro Oncol, 2016)
, et al.